project id: TCGA-ESCA; case submitter id: TCGA-LN-A5U6; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.96; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.38; rna integrity number: 8.3; age at index: 54; days to birth: -19840; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1958; age at diagnosis: 19840; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 375.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Yes; cigarettes per day: 1.3150684931506849; pack years smoked: 24.0; is ffpe: false; composition: Not Reported; days to collection: 127; days to sample procurement: 0; initial weight: 410.0; portion submitter id: TCGA-LN-A5U6-01A-11; percent lymphocyte infiltration: 4.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 55.0; percent tumor cells: 40.0; percent tumor nuclei: 80.0;